foxo4 dri peptide benefits cancer FOXO4-DRI 2MG/5MG/10MG VIAL – UMBRELLA Labs FOXO4-DRI Peptide foxo4-dri peptide benefits FOXO4-DRI: Human

Int J Food Sci Technol

34 : S65S72

Molecular Characteristics Molecular Type: Synthetic pentadecapeptide research compound Structure: Linear peptide chain (15 amino acids) Stability: High when stored under recommended laboratory conditions Molecular Weight: Sequence-dependent Molecular Stability and Storage Profile Supplied as a lyophilized powder for enhanced long-term stability Long-term storage: Store at 20C to preserve molecular integrity Sensitive to moisture and prolonged light exposure Predictable degradation above room temperature Reconstituted solutions remain stable for approximately 2448 hours under refrigeration Solubility and Reconstitution Characteristics Bacteriostatic water Sterile saline Acidic buffers Compatible analytical-grade organic solvents Technical Specifications product Name BPC-157 10mg cas 137525-51-0 purity 99% (HPLC verified) unit Size 10 mg vial form Lyophilized powder synthesis Solid-Phase Peptide Synthesis (SPPS) analytical HPLC, Mass Spectrometry, UV Spectrophotometry molecular Structure Linear peptide chain stability High when stored under recommended conditions Analytical Validation and Quality Assurance High-Performance Liquid Chromatography (HPLC) purity confirmation Mass Spectrometry (MS) molecular identity and sequence verification UV spectrophotometric concentration analysis Batch identity and consistency verification Endotoxin and microbial contamination screening Regulatory and Compliance Statement BPC-157 10mg is supplied strictly for laboratory research and scientific investigation

Pernicious anemia can present very similarly to Hashimotos